 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Circulating Tumor DNA in a Breast Cancer Patient's Plasma Represents Driver Alterations in the Tumor Tissue |
| Jieun Lee, Sung-Min Cho, Min Sung Kim, Sug Hyung Lee, Yeun-Jun Chung, Seung-Hyun Jung |
|
Genomics Inform. 2017;15(1):48-50. Published online March 29, 2017 DOI: https://doi.org/10.5808/GI.2017.15.1.48 |
|
Circulating Tumor DNA in a Breast Cancer Patient's Plasma Represents Driver Alterations in the Tumor Tissue Genomics & Informatics. 2017;15(1):48  Liquid Biopsy in Breast Cancer: Circulating Tumor Cells and Circulating Tumor DNA Translational Research in Breast Cancer. 2021;337-361 Concordance of Genomic Alterations between Circulating Tumor DNA and Matched Tumor Tissue in Chinese Patients with Breast Cancer Journal of Oncology. 2020;2020:1-8 Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA Tumor Biology. 2018;40(5):101042831877616 The emerging role of circulating tumor cells in breast cancer Cancer Cytopathology. 2012;120(3):161-166 Subtyping of metastatic breast cancer based on plasma circulating tumor DNA alterations: An observational, multicentre platform study eClinicalMedicine. 2022;51:101567 Cell-Free Nucleic Acids in Plasma and Serum (CNAPS), Circulating Tumor DNA (ctDNA) Encyclopedia of Cancer. 2016;901-901 Current Status of Circulating Tumor Cells, Circulating Tumor DNA, and Exosomes in Breast Cancer Liquid Biopsies International Journal of Molecular Sciences. 2020;21(24):9457 Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer Tumor Biology. 2014;36(1):7-19 Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients Lung Cancer. 2013;82(2):373-374 |
